Trang chủ › Bạch cầu tủy cấp › North Carolina › Durham
Thử nghiệm lâm sàng cho Bạch cầu tủy cấp tại Durham, NC
33 nghiên cứu cho Bạch cầu tủy cấp đang tìm kiếm người tham gia tại các cơ sở ở Durham và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Đang tuyểnGiai đoạn 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Cách 10 dặm
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Đang tuyểnNghiên cứu quan sátChào đón tình nguyện viên khỏe mạnh
- Durham VA Medical Center, Durham
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Duke University Medical Center, Durham
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Duke University Medical Center, Durham
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Duke University Medical Center, Durham
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Đang tuyểnGiai đoạn 2
- Duke University Medical Center, Durham
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Đang tuyểnGiai đoạn 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Cách 10 dặm
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Đang tuyểnGiai đoạn 1/2
- Duke University Medical Center, Durham
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Đang tuyểnGiai đoạn 1
- University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Đang tuyểnGiai đoạn 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · Cách 10 dặm
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Đang tuyểnGiai đoạn 3
- US-Chapel Hill-UNCNORTHCAROLINA, Chapel Hill · Cách 10 dặm
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Đang tuyểnGiai đoạn 1/2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Cách 10 dặm
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Đang tuyểnGiai đoạn 1
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Cách 10 dặm
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Đang tuyểnGiai đoạn 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · Cách 10 dặm
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Đang tuyểnGiai đoạn 1
- University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Đang tuyểnGiai đoạn 1/2
- Research Site, Durham
- Research Site, Chapel Hill · Cách 10 dặm
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Đang tuyểnGiai đoạn 2
- University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Đang tuyểnNghiên cứu quan sát
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Đang tuyển
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · Cách 10 dặm
Registry of Older Patients With Cancer
Đang tuyểnNghiên cứu quan sát
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Cách 10 dặm
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Đang tuyểnGiai đoạn 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
A Study of Revumenib and Mezigdomide in People With Leukemia
Đang tuyểnGiai đoạn 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · Cách 10 dặm
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation
Đang tuyểnGiai đoạn 1
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Đang tuyểnGiai đoạn 1
- University of North Carolina, Chapel Hill · Cách 10 dặm
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Đang tuyểnGiai đoạn 2/3
- Duke University, Durham
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Đang tuyểnGiai đoạn 1/2
- Duke University, Durham
- UNC Hospital, Chapel Hill · Cách 10 dặm
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Đang tuyểnGiai đoạn 2
- University of North Carolina, Chapel Hill · Cách 10 dặm
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Đang tuyểnGiai đoạn 1
- Duke Blood Cancer Center, Durham
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Đang tuyểnGiai đoạn 1
- Duke Cancer Center, Durham
Novel Digital Application for Patients With Acute Leukemia
Đang tuyển
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Đang tuyểnNghiên cứu quan sát
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Cách 10 dặm
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Đang tuyểnGiai đoạn 1/2
- Duke University Medical Center, Durham
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Đang tuyểnChào đón tình nguyện viên khỏe mạnh
- Duke University, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Cách 10 dặm
Thử nghiệm cho Bạch cầu tủy cấp tại các thành phố khác
- Houston, TX85 nghiên cứu
- New York City, NY51 nghiên cứu
- Boston, MA44 nghiên cứu
- Seattle, WA41 nghiên cứu
- Baldwin Park, CA40 nghiên cứu
- Columbus, OH35 nghiên cứu
- Philadelphia, PA34 nghiên cứu
- Atlanta, GA31 nghiên cứu
- Tampa, FL29 nghiên cứu
- Chicago, IL26 nghiên cứu
- Portland, OR25 nghiên cứu
- Washington, DC24 nghiên cứu
Các nghiên cứu khác tại Durham
- Ung thư vú64 nghiên cứu
- Ung thư (mọi loại)58 nghiên cứu
- Ung thư phổi không tế bào nhỏ39 nghiên cứu
- U tủy xương đa phát37 nghiên cứu
- Ung thư di căn33 nghiên cứu
- Ung thư tuyến tiền liệt32 nghiên cứu
- Ung thư phổi32 nghiên cứu
- Ung thư đại trực tràng28 nghiên cứu
- Ung thư buồng trứng27 nghiên cứu
- Bạch cầu lympho mạn tính27 nghiên cứu
- Suy tim26 nghiên cứu
- Ung thư tụy24 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 6 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.